Corporate Profile
bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. The company’s mission is to advance the care of patients with life threatening diseases worldwide. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.
Stock Quote
BLUE (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Change (%) Stock is Down 1.17 (5.46%)
Data as of 04/23/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
03/27/14bluebird bio Announces First Patient Transplanted in Phase 1/2 Northstar Study for the Treatment of Beta-ThalassemiaPrinter Friendly Version
03/05/14bluebird bio Reports Fiscal Year End 2013 Financial ResultsPrinter Friendly Version
02/26/14bluebird bio to Present at the Cowen and Company Health Care ConferencePrinter Friendly Version
02/05/14bluebird bio to Present at the Leerink Global Healthcare ConferencePrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.